ECSP972208A - NEW TRICYCLIC CYANOIMINS AND USEFUL AS PROTEIN TRANSFERASE INHIBITORS FARNESILO - Google Patents

NEW TRICYCLIC CYANOIMINS AND USEFUL AS PROTEIN TRANSFERASE INHIBITORS FARNESILO

Info

Publication number
ECSP972208A
ECSP972208A ECSP972208A ECSP972208A EC SP972208 A ECSP972208 A EC SP972208A EC SP972208 A ECSP972208 A EC SP972208A EC SP972208 A ECSP972208 A EC SP972208A
Authority
EC
Ecuador
Prior art keywords
protein transferase
farnesilo
cyanoimins
useful
transferase inhibitors
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Anil K Saksena
Raymond G Lovey
Alan B Cooper
Ronald J Doll
Viyyoor Moopil Girijavallabhan
Jagdish A Desai
James J S Wang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP972208 priority Critical patent/ECSP972208A/en
Publication of ECSP972208A publication Critical patent/ECSP972208A/en

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describen nuevos compuestos triciclos de N-cianoimina y composiciones farmacéuticas que son inhibidores de la enzima, transferasa de proteina farnseilo. Asi mismo se describe un método para inhibir la función Ras y por lo tanto para inhibir el desarrollo anormal de células. El método comprende administrar los nuevos compuestos N-cianoiminas triciclicas a un sistema biológico. En particular el método inhibe el desarrollo anormal de células en mamíferos tales como un ser humano.Novel tricyclic N-cyanoimine compounds and pharmaceutical compositions are described that are inhibitors of the enzyme, farnseyl protein transferase. Likewise, a method is described to inhibit Ras function and therefore to inhibit abnormal cell development. The method comprises administering the new tricyclic N-cyanoimine compounds to a biological system. In particular, the method inhibits abnormal cell development in mammals such as a human.

ECSP972208 1997-07-30 1997-07-30 NEW TRICYCLIC CYANOIMINS AND USEFUL AS PROTEIN TRANSFERASE INHIBITORS FARNESILO ECSP972208A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP972208 ECSP972208A (en) 1997-07-30 1997-07-30 NEW TRICYCLIC CYANOIMINS AND USEFUL AS PROTEIN TRANSFERASE INHIBITORS FARNESILO

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP972208 ECSP972208A (en) 1997-07-30 1997-07-30 NEW TRICYCLIC CYANOIMINS AND USEFUL AS PROTEIN TRANSFERASE INHIBITORS FARNESILO

Publications (1)

Publication Number Publication Date
ECSP972208A true ECSP972208A (en) 1998-09-22

Family

ID=42043038

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP972208 ECSP972208A (en) 1997-07-30 1997-07-30 NEW TRICYCLIC CYANOIMINS AND USEFUL AS PROTEIN TRANSFERASE INHIBITORS FARNESILO

Country Status (1)

Country Link
EC (1) ECSP972208A (en)

Similar Documents

Publication Publication Date Title
ES2177789T3 (en) LHRH ANTAGONIST PEPTIDES.
AR003938A1 (en) TRICYCLIC UREA COMPOUNDS USEFUL FOR THE INHIBITION OF THE FUNCTION OF PROTEIN G AND FOR THE TREATMENT OF PROTEOLYTIC DISEASES, PHARMACEUTICAL COMPOSITION, AND THE USE OF THE SAME FOR THE PREPARATION OF MEDICINES.
GT199900070A (en) DERIVATIVES OF ISOTIAZOLE, USEFUL AS ANTI-CANCER AGENTS.
CU23393A3 (en) INHIBITING COMPOUNDS OF RAF KINASA AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR004357A1 (en) 1-PHENYL-2-DIMETHYLAMINOMETHYL-CYCLOHEXAN-1-OL COMPOUNDS, AND PREPARATION PROCEDURE FOR SUCH COMPOUNDS.
AR002277A1 (en) USEFUL COMPOUNDS AS THROMBIN INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PEPTIDOMIMETIC AND PEPTIDOMIMETIC SUBSTANCES OF SERINPROTEASE.
ES2075050T3 (en) PEPTIDES THAT HAVE A T-CELL COOPERATOR ACTIVITY
PT1093819E (en) COMPOUNDS AND COMPOSITIONS FOR THE SUPPLY OF ACTIVE AGENTS
ECSP941122A (en) DERIVATIVES OF 5-ARYLINDOLS
ID29393A (en) COMPOSITION OF CANCER TREATMENT AND METHOD OF USING NATURAL PLANT ESENSIL OILS
EA199900045A1 (en) DERIVATIVES OF SPIROPIPERIDINE AND THEIR USE AS THERAPEUTIC AGENTS
AR008991A1 (en) DIMETHYL- (3-ARYL-BUT-3-ENYL) -AMINE COMPOUNDS, PROCEDURES FOR THEIR PREPARATION AND APPLICATION OF THEM
ES2186783T3 (en) DERIVATIVES OF DOLASTATINE, ITS PREPARATION AND USE.
ES2076595T3 (en) DERIVATIVES OF AMIDINOPHENYLALANINE, PROCEDURE FOR ITS PREPARATION, ITS EMPLOYMENT AND AGENTS THAT CONTAIN THEM.
CO5050328A1 (en) SOLVENT SYSTEM FOR THE BEST PENETRATION OF PHARMACEUTICAL COMPOUNDS
ES2104133T3 (en) COSMETIC OR PHARMACEUTICAL COMPOSITIONS CONTAINING GELEROPHOSPHOLIPIDS DESACLATED FOR TOPICAL USE.
AR009809A1 (en) DERIVATIVES OF 10,13,15-TRIOXATRICICLO [9.2.1 (9.6)] - PENTADECANONE, PROCEDURES FOR ITS PREPARATION AND MEDICINES CONTAINING THESE COMPOUNDS
ES2171743T3 (en) DERIVATIVES OF AMIDINES AND ISOTIOURES AS INHIBITORS OF THE SYNTHETIC ENZYME OF NITRIC OXIDE.
AR004129A1 (en) NEW GLYCOMIMETIC AGENTS AS SELECTIN AND MEDICATION ANTAGONISTS WHO ACT INHIBITING INFLAMMATION.
AR008781A1 (en) FURANO NITRONA COMPOUNDS
AR012989A1 (en) NOVEL SULFONAMIDE INHIBITORS FROM FARNESIL-PROTEIN TRANSFERASE.
ECSP972208A (en) NEW TRICYCLIC CYANOIMINS AND USEFUL AS PROTEIN TRANSFERASE INHIBITORS FARNESILO
AR004484A1 (en) NEW 1,2,3,4-TETRAHIDRO-2-NAFTALENAMINAS FENILO-SUBSTITUTED IN THE AROMATIC RING, ITS PREPARATION, ITS THERAPEUTIC APPLICATIONS AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ES2086195T3 (en) NEW DERIVATIVES PSEUDOPEPTIDICOS OF ANTAGONIST ACTIVITY OF BRADIQUININA, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
EA199700223A1 (en) BICYCLIC ANTAGONISTS OF TACHIKININS, THEIR RECEIVING AND APPLICATION IN THE PHARMACEUTICAL COMPOSITION